Skip to main content
. 2019 Nov 28;8(12):595. doi: 10.3390/antiox8120595

Table 2.

Association between plasma IL-6 concentration and CRC risk stratified by anatomic site.

Plasma IL-6 Concentration (pg/mL)
Q1 (<0.98) Q2 (0.98 to <1.36) Q3 (1.36 to <2.04) Q4 (≥2.04) P for Trend
Colorectal cancer
No. controls/cases 328/52 328/94 328/154 328/354
Crude OR (95% CI) 1.0 (ref) 1.81 (1.25–2.62) 2.96 (2.09–4.20) 6.81 (4.90–9.46) <0.001
Multivariable OR (95% CI) a 1.0 (ref) 1.97 (1.24–3.11) 2.82 (1.82–4.37) 6.23 (4.10–9.45) <0.001
Colon cancer
No. controls/cases 328/32 328/46 328/80 328/176
Crude OR (95% CI) 1.0 (ref) 1.44 (0.89–2.31) 2.50 (1.61–3.87) 5.50 (3.66–8.26) <0.001
Multivariable OR (95% CI) a 1.0 (ref) 1.63 (0.94–2.84) 2.33 (1.39–3.92) 4.77 (2.93–7.76) <0.001
Rectal cancer
No. controls/cases 328/20 328/48 328/72 328/168
Crude OR (95% CI) 1.0 (ref) 2.40 (1.39–4.13) 3.60 (2.14–6.05) 8.40 (5.16–13.69) <0.001
Multivariable OR (95% CI) a 1.0 (ref) 2.42 (1.29–4.55) 3.48 (1.90–6.39) 8.06 (4.52–14.39) <0.001

Q, quartile. REF: Reference. a Multivariable odds ratio (OR) was adjusted for age, sex, BMI, education level, occupation, income, smoking status, alcohol consumption, physical activity, first-degree family history of CRC, and total energy intake. Significant p-values that met the 5% level.